title: Intravitreal triamcinolone.
authors.forename: Mark C
authors.initials: MC
authors.lastname: Gillies
authors.forename: Judy M
authors.initials: JM
authors.lastname: Simpson
authors.forename: Meidong
authors.initials: M
authors.lastname: Zhu
authors.forename: Grace
authors.initials: G
authors.lastname: Hunt
authors.forename: Haipha
authors.initials: H
authors.lastname: Ali
authors.forename: Christine
authors.initials: C
authors.lastname: Gaston
mesh_terms: D003131:Combined Modality Therapy; D003930:Diabetic Retinopathy / Q000503:physiopathology / Q000628:therapy*; D004311:Double-Blind Method; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D007267:Injections; D017075:Laser Coagulation / Q000379:methods*; D008269:Macular Edema / Q000503:physiopathology / Q000628:therapy*; D011446:Prospective Studies; D014222:Triamcinolone Acetonide / Q000008:administration & dosage*; D014792:Visual Acuity / Q000502:physiology; D014822:Vitreous Body
chemical_list: D005938:Glucocorticoids; D014222:Triamcinolone Acetonide